share_log

苑东生物(688513.SH):11月公司未实施股份回购

Chengdu Easton Biopharmaceuticals (688513.SH): The company did not implement share repurchases in November.

Gelonghui Finance ·  Dec 2, 2024 17:59

Gelonghui reported on December 2 that chengdu easton biopharmaceuticals (688513.SH) announced that in November 2024, the company did not implement share repurchases. As of the end of November 2024, the company has cumulatively repurchased 3,316,769 shares through centralized bidding, accounting for 1.8788% of the company’s current total share capital, with a highest purchase price of 56.05 yuan/share, a lowest price of 28.12 yuan/share, and a total transaction amount of 123,694,177.73 yuan (excluding stamp duty, transaction commissions, and other transaction costs).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment